suzanne ameringer, phd, rn r. k. elswick, jr. phd wally smith, md virginia commonwealth university
DESCRIPTION
Correlations between Biological and Behavioral Factors and Fatigue in Sickle Cell Disease in Adolescents and Young Adults. Suzanne Ameringer, PhD, RN R. K. Elswick, Jr. PhD Wally Smith, MD Virginia Commonwealth University. Council for the Advancement of Nursing Science - PowerPoint PPT PresentationTRANSCRIPT
Correlations between Biological and Behavioral Factors and Fatigue in Sickle Cell Disease in Adolescents and Young AdultsSuzanne Ameringer, PhD, RNR. K. Elswick, Jr. PhDWally Smith, MDVirginia Commonwealth University
Council for the Advancement of Nursing Science2012 State of the Science Congress on Nursing Science
Washington, DC
Sickle Cell Disease
Genetic hemolytic disorders characterized by: Chronic profound hemolytic anemia
Vaso-occlusion
Inflammatory reactions
Worldwide: 300,000 infants born with SCD annually (WHO, 2010)
US: 1 in 500 AA, 1 in 36,000 HA (NHLBI)
Life expectancy- early middle age
Fatigue in SCDFatigue affects quality of life (cognitive function,
well-being, daily activities) (Falk, 2007; Kralik, 2005, Ream, 1997; Smith, 2010)
Illness characteristics that may lead to or increase SCD fatigue: Anemia, inflammation, pain, anxiety, depressive symptoms, stress
Research on SCD fatigue sparse Tired, lack energy (While, 2004) Vitality lower compared to healthy individuals (McClish, 2005)
Adolescents and young adults (AYA) with SCD particularly vulnerable as begin to pursue life goals
Potential Correlates of SCD fatigue
Anemia (Cella, 2002; Yeh, 2008)
Pain (Ballas, 2006; McClish, 2005)
Anxiety and depressive symptoms (Cathebras, 1992; Whitsett, 2008)
Stress (Aaronson, 2003; Kerr, 2008)
Sleep quality (Lavidor, 2003; Owen, 1999)
Inflammation Sickled RBCs disrupt and stimulate the vascular endothelium
causing inflammation.
Potential inflammatory cytokines involved with fatigue Interleukin (IL) – 1
Affects hippocampal activity (integral to sleep regulation) (Luk, 1999)
Tumor necrosis factor(TNF) – α Alters slow-wave activity associated with non-rapid eye movement
sleep (Yoshida, 2004)
IL - 1 and Tumor necrosis factor(TNF) – α associated with: Decreased muscle strength (Visser, 2002) Decreased exercise capacity (Carmichael, 2006)
IL - 6 Interferes with stage of REM sleep (Spath-Schwalbe, 1998)
Purpose
Examine the relationships between biological and behavioral factors and fatigue in adolescents and young adults with SCD
Conceptual Model of SCD Fatigue
Strategies to Manage Fatigue
Fatigue
Quality of Life
Neuroendocrine & Immunological
Mediators
Biological andBehavioralVariables
Inflammation, oxygenation, pain, anxiety, depressive symptoms, sleep
quality, stress Personal and
Disease-relatedCofactors
Age, gender, disease severity, crisis status
Sickle Cell
Disease
MethodsDesign: Cross-sectional, descriptiveSample:
Inclusion criteria: Ages 15-30 years with SCD
Exclusion criteria: Participant’s (and/or minor’s parent’s) inability to read and write
in English Women who were pregnant
Procedure: Recruited from VCUHS pediatric and adult hematology clinics
and units
• Brief Fatigue Inventory (BFI)• PROMIS Fatigue Short Form• Multidimensional Fatigue Symptom Inventory-SF (MFSI-SF)
Fatigue
• Inflammation: IL-1b, IL-6, IL-10, TNF-α• HemoglobinBiological
• Age• Sex• Disease Severity
Demo/Disease
• Pain: Brief Pain Inventory (BPI)• Stress: Perceived Stress Scale (PSS)• Anxiety and depression: State Trait Anxiety Inventory (STAI)• Sleep quality (Pittsburgh Sleep Quality Index (PSQI)
Behavioral
Sample Characteristics (N = 60)Variable
Mean (SD)Age (range 15-30 yrs) 22.53 (4.12)Hemoglobin (g/dL) (range 6 – 14.9) 9.6 (2.21)
n (%)Sex Male 24 (40.0) Female 36 (60.0)Genotype
SS 39 (65.0) SC 11 (18.4) Sβ+ Thalassemia 6 (10.0) Sβo Thalassemia 2 (3.3) Unknown 2 (3.3)
Disease Severity Mild 15 (25.0) Severe 45 (75.0)
Mean (SE) Fatigue Measures: Total Scores
Measure# of
Items M (SE)Potential
Range
BFI Total 9 4.3 (0.28) 0–10
MFSI-SF Total 30 14.9 (2.62) -24–96
PROMIS Fatigue SF 7 19.8 (0.68) 7–35
Correlations between Fatigue Measures and Cytokines
IL-1b IL-6 IL-10 TNF-α
BFI
BFI Usual -0.06 0.19 -0.20 0.03
BFI Worst -0.15 0.17 -0.22 -0.16
BFI Interference -0.10 0.13 -0.12 -0.09
PROMIS -0.13 0.17 0.09 0.03
MFSI-SF -0.18 0.06 -0.01 -0.18
Hemoglobin (g/dL)
6 8 10 12 14 16
BFI
Tot
al
0
2
4
6
8
10
p-value = 0.19
Hemoglobin (g/dL)
6 8 10 12 14 16
MFS
I-SF
Tota
l
-40
-20
0
20
40
60
80
p-value = 0.82
Hemoglobin (g/dL)
6 8 10 12 14 16
PR
OM
IS F
atig
ue S
F
5
10
15
20
25
30
35
p-value = 0.03
Fatigue and HemoglobinScatterplot with Linear Regression Line
BFI MFSI-SF
PROMIS
Variable BFI PROMIS MFSI-SFBPI average pain 0.51*** 0.31* 0.48***
BPI worst pain 0.65*** 0.41*** 0.40**
BPI interference 0.55*** 0.42*** 0.45***STAI – State anxiety 0.44*** 0.45*** 0.70***STAI – Trait anxiety 0.38** 0.35** 0.55***PSS – stress 0.41*** 0.37** 0.69***CESD – depressive mood 0.42*** 0.45*** 0.45***PSQI – sleep quality 0.53*** 0.47*** 0.51***Age 0.24 0.07 0.14
* p < 0.05, **p < 0.01, ***p≤0.001
Correlations between Fatigue and Behavioral Variables
Mean (SE) Fatigue Scores by Sex
Measure Female (n = 36) Male (n = 24) t P-value
BFI Total 4.63 (0.39) 3.82 (0.37) -1.51 0.07
PROMIS 21.31 (0.85) 17.58 (0.97) -2.89 0.0029*
MFSI total 15.42 (3.70) 14.09 (3.59) -0.26 0.4
Mean (SE) Fatigue Scores by Disease Severity
Measure Mild (n = 15) Severe (n = 45) t P-value
BFI Total 4.24 (0.55) 4.33 (0.33) 0.14 0.56
PROMIS 19.20 (1.63) 20.02 (0.73) 0.46 0.67
MFSI total 15.41 (5.85) 14.72 (2.95) -0.11 0.46
Summary
All fatigue measures were significantly associated with stress, anxiety, sleep, depressive symptoms, pain
Fatigue scores were not significantly associated with cytokines (inflammation), hemoglobin (except PROMIS), or age
Fatigue scores did not differ by sex(except PROMIS) or disease severity
Limitations
Cross-sectional
Sample – convenience, one institution
No age-matched controls
Small sample size
Conclusions Various correlates of fatigue suggest common
etiologies may be at play
Distinguishing etiologies may be difficult
Fatigue may be a measure of health -May be important to screen for other conditions
Longitudinal studies needed to examine the trajectory of fatigue
Need interventions to better manage or reduce fatigue
AcknowledgementsNINR (P30 NR011403,
Center of Excellence for Biobehavioral Approaches to Symptom Management (Grap, PI).
Mary Jo GrapNancy McCainDebra LyonRita PicklerShari CordonYui Matsuda
Julie StillmanErica GregoryVirginia Smith India SislerJennifer NewlinPatients and families at the
VCU pediatric and adult clinics